Some psychiatrists feel MDMA is a double-edged sword: it creates a surge of serotonin that makes users feel better in the short term, but the ensuing serotonin depletion can exacerbate depression, according to psychiatrist Dr. Dion Metzger.
"The issue with controlled substances such as MDMA and other psychedelics is that their harmful effects outweigh the benefits," Dr. Metzger says. "Once the bad is greater than the good, it's not therapeutic."
And there are certainly no examples of other legal prescription medications leading to accidental death or addiction or anything. Oh, wait... there are.
Recently, however, the DEA has approved studies sponsored by MAPS that will test MDMA's efficacy as a psychotherapeutic tool. "Our main priority now is developing MDMA and cannabis into prescription medicines through the FDA process," Ginsberg says.
If all goes according to MAPS' plan, molly might be legal by 2021.
LSD and shrooms might be options, too
Like MDMA, LSD currently has no approved medical uses in the United States, but its therapeutic potential has researchers intrigued. In addition to MAPS' work researching the drug, scientists in the United Kingdom earlier this year published the first images of a brain on LSD.